# Stryker declares an $0.88 per share quarterly dividend
Canonical URL: https://biopharmsignal.com/news/SYK/stryker-declares-an-0-88-per-share-quarterly-dividend-6211bc27
Ticker: SYK
Company: Stryker
Source: Stryker
Published: 2026-05-07 12:00 EST
Original Source URL: https://investors.stryker.com/press-releases/news-details/2026/Stryker-declares-an-0-88-per-share-quarterly-dividend-acbf45a80/default.aspx
## Summary

Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com . Contacts For investor inquiries: Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.mead@stryker.com For media inquiries: Kim Montagnino, Vice President, Chief Communications Officer at

## Article Body
Home Stock Information Stock Quote

Stock Chart

Historical Stock Quote

Analyst Coverage

Dividend History

Financial Information Quarterly Results

Annual Reports

SEC Filings

Proxy Materials

Governance Governance Documents

Executive Management

Board of D irectors

Press Releases

Events & Presentations

Investor Resources Investor Contacts

Investor Email alerts

INVESTOR INQUIRY/COMMENT

RSS Feeds

View all news

Stryker declares an $0.88 per share quarterly dividend

05/07/2026

Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com .

Contacts

For investor inquiries: Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.mead@stryker.com

For media inquiries: Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com

Source: Stryker Corporation

Categories: Press Releases

View all news
## Recent Company News
- 2026-07-01 12:00 EST — [Stryker to announce second quarter 2026 financial results](https://biopharmsignal.com/news/SYK/stryker-to-announce-second-quarter-2026-financial-results-94b73874) — Source: Stryker
- 2026-05-07 20:05 EST — [Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio](https://biopharmsignal.com/news/SYK/stryker-completes-acquisition-of-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio) — Source: Stryker
- 2026-05-07 12:00 EST — [Stryker declares an $0.88 per share quarterly dividend](https://biopharmsignal.com/news/SYK/stryker-declares-an-0-88-per-share-quarterly-dividend-6211bc27) — Source: Stryker
- 2026-05-01 12:00 EST — [Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference](https://biopharmsignal.com/news/SYK/stryker-to-participate-in-the-bank-of-america-securities-2026-global-healthcare-conference) — Source: Stryker
- 2026-04-30 20:05 EST — [Stryker reports first quarter 2026 operating results](https://biopharmsignal.com/news/SYK/stryker-reports-first-quarter-2026-operating-results) — Source: Stryker
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)